Founder & CEO

Insilico Medicine, Inc

Passionate about developing and applying deep learning methods to drug discovery.

Dr. Zhavoronkov is the founder and CEO of Insilico Medicine, a Baltimore-based leader in the next-generation AI for drug discovery, biomarker development, and aging research. Prior to Insilico, he worked in senior roles at ATI Technologies, NeuroG Neuroinformatics, the Biogerontology Research Foundation and co-founded YLabs.AI. Since 2012 he published over 100 peer-reviewed research papers and two books. He organizes the annual Aging Forum and Artificial Intelligence for Healthcare Forum at EMBO/Basel Life in Basel. Dr. Zhavoronkov is an adjunct professor at the Buck Institute for Research on Aging.

Latest insights

Fri Sep 6 2019

Pharma’s AlphaGo Moment: For the First Time AI Has Designed and Validated...

Fri Mar 13 2020

Did an experimental drug help a U.S. coronavirus patient?

Fri Jan 10 2020

MoneyBall Medicine: Tom Davenport on the Analytics Gap in Healthcare

Wed Dec 18 2019

MoneyBall Medicine – Milind Kamkolkar on Seeing the Forest and the Tr...

Never miss an announcement